AGP Picks
View all

Your daily news update on Asia and the Pacific

Provided by AGP

The Asia Pacific Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Asia Pacific Examiner.

Press releases published on April 9, 2026

Cerevance to Present Positive Phase 2 Solengepras Data in Parkinson’s Disease at the American Academy of Neurology 2026 Annual Meeting
Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026
Trident Digital Tech Partners with Israel’s Cybersecurity Leading Firm Memcyco to Launch Asia-Pacific’s First Preemptive AI Fraud Defense
Kyverna Therapeutics to Host Conference Call on New Data Across Neuroimmunology Franchise at AAN 2026
AIM ImmunoTech to Participate in Live Virtual Investor Closing Bell Event
Liner launches Figure Generator on Liner Scholar, expanding AI-powered research from citation to visualization
SONORO GOLD ANNOUNCES FURTHER EXPANSION OF CERRO CALICHE GOLD PROPERTY
OwlTing Group (NASDAQ: OWLS) Expands Visa Collaboration to Support U.S. Debit Card Funding of USDC Transactions
La fusion entre PDI et Robex entre dans sa phase de mise en œuvre
Fusion von PDI und Robex auf dem Weg zur Umsetzung
WF HOLDING LIMITED Announces 1-for-5 Reverse Share Split
Allied Biofuels Uzbekistan Secures Presidential Decree and Related Incentives for Sustainable Aviation Fuels Project
NevGold Intercepts 1.11% Antimony Over 6.1 Meters, Within 1.93 g/t AuEq Over 100.6 Meters (1.07 g/t Au And 0.22% Antimony) From Surface; Focus On Maiden Antimony-Gold Mineral Resource Estimate and Near-Term Antimony Production
Entrée Resources Provides JV Licenses Update and Drill and Regional Exploration Results
Dynacor Group Announces CEO Transition
Groupe Dynacor annonce une transition au poste de chef de la direction
Big Bear Gold Corp. Announces AGM Results and Adoption of Omnibus Long-Term Incentive Plan
NIOB Authorized to Drill at Two More Québec Projects
InflaRx Reports New Mechanistic Data for Izicopan Supporting its Potential as a Best-in-Class C5aR Inhibitor
Invivyd Announces REVOLUTION Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate VMS063 for Treatment and Prevention of Measles

Share us

on your social networks:

Sign up for:

The Asia Pacific Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.